Evidence map›Paper›PMID 30555031›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2019

Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.

Ganesh M Babulal, Yakeel T Quiroz, Benedict C Albensi, Eider Arenaza-Urquijo, Arlene J Astell, Claudio Babiloni, Alex Bahar-Fuchs, Joanne Bell, Gene L Bowman, Adam M Brickman and 49 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 382 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
382citing papers in PubMed, 9 pooled it
23.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

382 citing papers in PubMed, 9 syntheses or guidelines pooled it, 529 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Multimorbidity, Polypharmacy, and Neighborhood Disadvantage as Determinants of Cognitive Performance in the ARCHES Cohort.Journal of applied gerontology : the official journal of the Southern Gerontological Society · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Adverse policing as a social exposome pathway: Implications for depression, cognition, and dementia risk.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Wellbeing trajectories and dementia risk among Mexican-origin adults living in the U.S.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2026
    Article

322 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

59 authors at 20 institutions in 15 countries.

Ganesh M BabulalDepartment of Neurology and Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.
Yakeel T QuirozDepartment of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Benedict C AlbensiDivision of Neurodegenerative Disorders, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, Manitoba, Canada; Department of Pharmacology & Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada.
Eider Arenaza-UrquijoDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Arlene J AstellDepartment of Occupational Sciences & Occupational Therapy, University of Toronto, CA; School of Psychology and Clinical Language Sciences, University of Reading, UK.
Claudio BabiloniDepartment of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy; Department of Neuroscience, IRCCS-Hospital San Raffaele Pisana of Rome and Cassino, Rome and Cassino, Italy.
Alex Bahar-FuchsAcademic Unit for Psychiatry of Old Age, Department of Psychiatry, the University of Melbourne, Australia.
Joanne BellSyneos Health, Wilmington, NC, USA.
Gene L BowmanNutrition and Brain Health Laboratory, Nestlé Institute of Health Sciences, Lausanne, Switzerland; Department of Neurology, Layton Aging & Alzheimer's Disease Center, Oregon Health & Science University, Portland, OR, USA.
Adam M BrickmanTaub Institute for Research in Alzheimer's Disease and the Aging Brain, The Gertrude H. Sergievsky Center, Department of Neurology, Columbia University, New York, NY, USA.
Gaël ChételatInserm, Inserm UMR-S U1237, Université de Caen-Normandie, GIP Cyceron, Caen, France.
Carrie CiroDepartment of Occupational Therapy Education, University of Kansas Medical Center, Kansas City, KS, USA.
Ann D CohenDepartment of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Peggye Dilworth-AndersonGillings School of Global Public Health, University of North Carolina Chapel Hill, NC, USA.
Hiroko H DodgeDepartment of Neurology, Layton Aging and Alzheimer's Disease Center, Oregon Health & Science University, Portland, OR, USA.
Simone DreuxUndergraduate Program of History and Science, Harvard College, Cambridge, MA, USA.
Steven EdlandDepartment of Family Medicine and Public Health, University of California, San Diego, CA, USA.
Anna EsbensenDepartment of Pediatrics, University of Cincinnati College of Medicine & Division of Developmental and Behavioral Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Lisbeth EveredMelbourne Medical School, University of Melbourne, Australia.
Michael EwersInstitute for Stroke and Dementia Research, Klinikum der Universität München, Munich, Germany.
Keith N FargoMedical & Scientific Relations, Alzheimer's Association, Chicago, IL, USA.
Juan ForteaMemory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; Barcelona Down Medical Center, Fundació Catalana de Síndrome de Down, Barcelona, Spain.
Hector GonzalezDepartment of Neurosciences and Shiley-Marcos Alzheimer's Disease Research Center, University of San Diego, CA, USA.
Deborah R GustafsonDepartment of Neurology, Section for NeuroEpidemiology, State University of New York - Downstate Medical Center, Brooklyn, NY, USA.
Elizabeth HeadSanders Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
James A HendrixMedical & Scientific Relations, Alzheimer's Association, Chicago, IL, USA.
Scott M HoferAdult Development and Aging, University of Victoria, British Columbia, CA, USA.
Leigh A JohnsonDepartment of Pharmacology & Neuroscience, University of North Texas Health Science Center, Fort Worth, TX, USA.
Roos JuttenVU University Medical Center, Department of Neurology, Amsterdam Neuroscience, Amsterdam, the Netherlands.
Kerry KilbornDepartment of Psychology, University of Glasgow, Glasgow, Scotland, UK.
Krista L LanctôtSunnybrook Research Institute of Psychiatry and Pharmacology, University of Toronto, Toronto, ON, Canada.
Jennifer J ManlyTaub Institute for Research in Alzheimer's Disease and the Aging Brain, The Gertrude H. Sergievsky Center, Department of Neurology, Columbia University, New York, NY, USA.
Ralph N MartinsAging and Alzheimer's Disease, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Australia.
Michelle M MielkeDepartment of Epidemiology, Mayo Clinic, Rochester, MN, USA; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Martha Clare MorrisDepartment of Internal Medicine, Rush University, Chicago, IL, USA.
Melissa E MurrayDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Esther S OhDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Mario A ParraSchool of Social Sciences, Department of Psychology, Heriot-Watt University, UK; Universidad Autónoma del Caribe, Barranquilla, Colombia; Neuroprogressive and Dementia Network, UK.
Robert A RissmanDepartment of Neurosciences, University of California San Diego School of Medicine, CA, USA.
Catherine M RoeDepartment of Neurology and Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.
Octavio A SantosDepartment of Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL, USA.
Nikolaos ScarmeasTaub Institute for Research in Alzheimer's Disease and the Aging Brain, The Gertrude H. Sergievsky Center, Department of Neurology, Columbia University, New York, NY, USA; Aiginition Hospital, 1st Neurology Clinic, Department of Social Medicine, Psychiatry and Neurology, National and Kapodistrian University of Athens, Athens, Greece.
Lon S SchneiderDepartment of Psychiatry and The Behavioral Sciences, University of Southern California, CA, USA.
Nicole SchupfDepartment of Epidemiology, Mailman School of Public Health Columbia University, New York, NY, USA.
Sietske SikkesMassachusetts General Hospital, Department of Neurology, Boston, MA, USA.
Heather M SnyderMedical & Scientific Relations, Alzheimer's Association, Chicago, IL, USA.
Hamid R SohrabiAging and Alzheimer's Disease, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Australia.
Yaakov SternDepartment of Neurology, Columbia University, New York, NY, USA; Department of Psychiatry, Columbia University, New York, NY, USA.
Andre StrydomDepartment of Forensic and Neurodevelopmental Science, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, UK.
Yi TangDepartment of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China.
Graciela Muniz TerreraCenters for Clinical Brain Sciences and Dementia Prevention, University in Edinburgh, Scotland, UK.
Charlotte TeunissenNeurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit University Medical Center, Amsterdam, the Netherlands.
Debora Melo van LentDepartment of Clinical Research, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Michael WeinbornAging and Alzheimer's Disease, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Australia.
Linda WesselmanVrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Donna M WilcockNeurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit University Medical Center, Amsterdam, the Netherlands.
Henrik ZetterbergUK Dementia Research Institute at UCL, London, UK; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Sid E O'BryantDepartment of Pharmacology & Neuroscience, University of North Texas Health Science Center, Fort Worth, TX, USA. Electronic address: sid.obryant@unthsc.edu.
International Society to Advance Alzheimer's Research and Treatment, Alzheimer's Association
Alzheimer’s Disease Neuroimaging Initiative · USAlzheimer's Association · USAmsterdam Neuroscience · NLEdith Cowan University · AUColumbia University · USJacksonville College · USOregon Health & Science University · USThe University of Melbourne · AUUniversity of North Texas · USCincinnati Children's Hospital Medical Center · USDivision of Undergraduate Education · USGerman Center for Neurodegenerative Diseases · DEHarvard University · USHeriot-Watt University · GBInserm · FRJohns Hopkins University · USKing's College London · GBMassachusetts General Hospital · USMayo Clinic · USMayo Clinic in Arizona · US

Funding

Smartphone-Based "Burst" Cognitive AssessmentsP01AG003991 · NIA · WASHINGTON UNIVERSITY · PI JOHN MORRIS · 1985 to 2026
$69.5M
WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI FAGAN, ANNE · 1985 to 2019
$52.1M
VASCULAR RISK AND COGNITIVE STATUS IN A LATINO POPULATIONP50AG005142 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BRASKIE, MEREDITH NICOLE · 1985 to 2019
$41.0M
Vulnerability to Alzheimers Disease in Down SyndromeP01HD035897 · NICHD · NEW YORK STATE OFFICE OF MENTAL HEALTH · PI TYCKO, BENJAMIN · 1998 to 2014
$19.2M
Health Disparities in Alzheimer's Disease and Mild Cognitive Impairment among Mexican AmericansR01AG054073 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI O'BRYANT, SID E, TOGA, ARTHUR W · 2017 to 2021
$12.6M
Michigan Alzheimer's Disease Core CenterP30AG053760 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALBIN, ROGER L · 2016 to 2020
$10.1M
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)R01AG046543 · NIA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HERRMANN, NATHAN, LANCTOT, KRISTA L. · 2014 to 2018
$8.1M
Translational Neuroscience CoreU54HD079123 · NICHD · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI WILSON, MARY A · 2014 to 2019
$7.9M
San Diego Resource Center for advancing Alzheimer's Research in Minority Seniors (ARMS)P30AG059299 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JOHN P. ELDER, PAUL E GILBERT · 2018 to 2026
$7.4M
An Alzheimer's Blood Test for Primary CareR01AG058537 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI O'BRYANT, SID E, YAFFE, KRISTINE · 2018 to 2020
$6.5M
Preclinical Alzheimer Disease and DrivingR01AG056466 · NIA · WASHINGTON UNIVERSITY · PI BABULAL, GANESH M · 2017 to 2021
$5.9M
Aging of Frontal Structure and Function in Down Syndrome and DementiaR01HD064993 · NICHD · UNIVERSITY OF KENTUCKY · PI HEAD, ELIZABETH, SCHMITT, FREDERICK · 2009 to 2019
$5.1M
Department of Health RP-DG-0611-10003Medical Research Council MR/S011277/1NIA NIH HHS P01 AG003991NIA NIH HHS P30 AG053760NIA NIH HHS P30 AG059299NIA NIH HHS P50 AG005142NIA NIH HHS P50 AG005681NIA NIH HHS R01 AG014673NIA NIH HHS R01 AG046543NIA NIH HHS R01 AG051848NIA NIH HHS R01 AG054073NIA NIH HHS R01 AG054449NIA NIH HHS R01 AG056466NIA NIH HHS R01 AG057684NIA NIH HHS R01 AG058537NIA NIH HHS R01 AG063887NIA NIH HHS R03 AG055482NIA NIH HHS R56 AG058533NICHD NIH HHS P01 HD035897NICHD NIH HHS R01 HD064993NICHD NIH HHS U54 HD079123NIH HHS DP5 OD019833
6 · The paper itself

Abstract

Alzheimer's disease and related dementias (ADRDs) are a global crisis facing the aging population and society as a whole. With the numbers of people with ADRDs predicted to rise dramatically across the world, the scientific community can no longer neglect the need for research focusing on ADRDs among underrepresented ethnoracial diverse groups. The Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART; alz.org/ISTAART) comprises a number of professional interest areas (PIAs), each focusing on a major scientific area associated with ADRDs. We leverage the expertise of the existing international cadre of ISTAART scientists and experts to synthesize a cross-PIA white paper that provides both a concise "state-of-the-science" report of ethnoracial factors across PIA foci and updated recommendations to address immediate needs to advance ADRD science across ethnoracial populations.

Indexed as

EthnicityHealthcare DisparitiesRacial GroupsAgedAlzheimer DiseaseBiomarkersBiomedical ResearchHumansBiomarkersAlzheimer's diseaseAlzheimer's related dementiasDiversityEthnicityEthnoracialTranslationalUnderserved

Identifiers

PMID30555031
PMCPMC6368893
OpenAlexW2903592416

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.